Current and Future Generic Prescription Drugs: Global Market Analysis

• 1.1 Scope and Objectives of Report
• 1.2 Methodology

2 Overview of the Generic Drug Market

• 2.1 History of the Generic Drug Market
• 2.2 History of the Generic Drug Approval Process
• 2.3 The Drug Approval Process

3 Generic Anti-Infectives

• 3.1 Overview
• 3.2 Conditions and Drug Products
• 3.2.1 Antibiotics and Antibacterial Agents
• 3.2.2 Antiviral Drugs
• 3.2.3 Antifungal Drugs
• 3.2.4 Antimalarial Drugs
• 3.2.5 Antiparasitic Drugs
• 3.2.6 Drugs to Treat Tuberculosis
• 3.2.7 Other Topical Anti-Infectives
• 3.3 Market Size and Growth
• 3.3.1 Total World Market
• 3.3.2 U.S. Mark
• 3.3.3 Rest of World Market
• 3.4 Competitor An

4 Generic Cancer Drugs

• 4.1 Overview
• 4.2 Conditions and Drug Products
• 4.2.1 Alkylating Cancer Drugs
• 4.2.2 Antimetabolite Cancer Drugs
• 4.2.3 Mitotic Inhibitor Cancer Drugs
• 4.2.4 Antineoplastic Antibiotic Cancer Drugs
• 4.2.5 Antineoplastic Hormone and Other Cancer Drugs
• 4.3 Market Size and Growth
• 4.3.1 Total World Market
• 4.3.2 U.S. Mark
• 4.3.3 Rest of World Market
• 4.4 Competitor An

5 Generic Cardiovascular Drugs

• 5.1 Overview
• 5.2 Conditions and Drug Products
• 5.2.1 ACE Inhibitors
• 5.2.2 Antiarrhythmia Drugs
• 5.2.3 Antihyperlipidemic Drugs
• 5.2.4 Adrenergic Blockers
• 5.2.5 Calcium Channel Blockers
• 5.2.6 Diuretics
• 5.2.7 Vasodilators
• 5.3 Market Size and Growth
• 5.3.1 Total World Market
• 5.3.2 U.S. Mark
• 5.3.3 Rest of World Market
• 5.4 Competitor An

6 Generic Central Nervous System Drugs

• 6.1 Overview
• 6.2 Conditions and Drug Products
• 6.2.1 CNS St
• 6.2.2 Antidepressants and Antimanic Agents
• 6.2.3 Antianxiety, Sedative, and Hypnotic Drugs
• 6.2.4 Antipsychotics
• 6.2.5 Anticonvulsants, Antispasmodics, and Muscle Relaxants
• 6.2.6 Parkinson’s Disease and Myasthenia Gravis Treatment Drugs
• 6.2.7 Analgesics and Anesthetics
• 6.3 Market Size and Growth
• 6.3.1 Total World Market
• 6.3.2 U.S. Ma
• 6.3.3 Rest of World Market
• 6.4 Competitor

7 Generic Gastrointestinal Drugs

• 7.1 Overview
• 7.2 Conditions and Drug Products
• 7.2.1 Histamine H2 Antagonists
• 7.2.2 Proton Pump Inhibitors
• 7.2.3 Antidiarrheals and Antispasmodics
• 7.2.4 Antiemetic Drugs
• 7.3 Market Size and Growth
• 7.3.1 Total World Market
• 7.3.2 U.S. Ma
• 7.3.3 Rest of World Market
• 7.4 Competitor

8 Generic Hormone, Endocrine, and Metabolic Disorder Drugs

• 8.1 Overview
• 8.2 Conditions and Drug Products
• 8.2.1 Diabetes Treatment Drugs
• 8.2.2 Female and Male Sex Hormones
• 8.2.3 Thyroid Hormones
• 8.2.4 Corticosteroids for Relevant Conditions
• 8.3 Market Size and Growth
• 8.3.1 Total World Market
• 8.3.2 U.S. Ma
• 8.3.3 Rest of World Market
• 8.4 Competitor

9 Generic Respiratory and Allergy Drugs

• 9.1 Overview
• 9.2 Conditions and Drug Products
• 9.2.1 Antihistamines and Decongestants
• 9.2.2 Bronc
• 9.2.3 Inhaled Corticosteroids and Antiasthmatic Agents
• 9.2.4 Cough Suppressants/Expectorants
• 9.3 Market Size and Growth
• 9.3.1 Total World Market
• 9.3.2 U.S. Ma
• 9.3.3 Rest of World Market
• 9.4 Competitor

10 Overall Market Summary
11 Generic Drug Industry Issues and Trends

• 11.1 Patent Legislation
• 11.2 Antitrust Agreements
• 11.3 Prescription Drugs for Senior Citizens
• 11.4 Generic Biologics

12 Company Profiles

• 12.1 Alpharma, Inc.
• 12.2 Andrx Corp
• 12.3 Barr Laboratories, Inc
• 12.4 Falcon Pharmaceuticals, Ltd.
• 12.5 Geneva Pharmaceuticals, Inc
• 12.6 IVAX Corp.
• 12.7 KV Pharmaceutical Co.
• 12.8 Mylan Laboratories, Inc.
• 12.9 Ranbaxy Laboratories Ltd.
• 12.10 Roxane Laboratories, Inc
• 12.11 Sicor, Inc.
• 12.12 Teva Pharmaceutical Industries Ltd.
• 12.13 Watson Pharmaceuticals, Inc

13 Company Directory